-
Featured
Interventional Cardiology Studies Boost Safety in TAVR, PCI
A Massachusetts General Hospital interventional cardiologist is using research to lower bleeding risk and incidence of stroke in percutaneous coronary intervention and transcatheter aortic valve replacement.
-
Paclitaxel-loaded Mesh Reduces Local Recurrence of Lung Cancer in Animal Model
Yolonda L. Colson, MD, PhD, and colleagues have developed a polymer mesh that can be loaded with a chemotherapeutic agent and implanted during resection to prevent local recurrence. Its use significantly improved survival in a mouse model of non–small-cell lung cancer.
-
Thoracic Anesthesia at Mass General
The Thoracic Anesthesia team at Massachusetts General Hospital provides care during surgeries for lung and airway diseases or obstruction, voice preservation, and more. Read their full annual report to learn about the team's accomplishments throughout 2022.
-
Short Term Mechanical Support Heart and Lung Symposium 2023
Experts from the Corrigan Minehan Heart Center of Massachusetts General Hospital are leading a course designed to educate participants in the multidisciplinary care of patients with acute heart and lung failure.
-
Robotic Approach to Lobectomy Safe and Feasible for Stage II–IIIA NSCLC
In a nationwide study, Massachusetts General Hospital researchers found robotic lobectomy for stage II–IIIA non–small cell lung cancer was associated with a lower conversion rate and length of stay than video-assisted thoracoscopic surgery, and all minimally invasive surgery conferred advantages over open surgery.
-
First-in-Human Trial: Implanted Microdevice for Testing Patient Sensitivity to Multiple Chemotherapeutic Agents in NSCLC
In a first-in-human trial conducted by Yolonda L. Colson, MD, PhD, and colleagues, a multidrug-eluting microdevice implanted intraoperatively into non-small cell lung tumors proved safe and feasible for in situ chemotherapeutic sensitivity testing and was reliably removable by pathologists.
Thoracic Surgery Contributors
-
David A. D'Alessandro, MD
Surgical Director, Heart Transplantation and Ventricular Assist Devices, Member of Faculty, Harvard Medical School
Recent Article
Ex Vivo Perfusion and Transplantation of Hearts Donated After Circulatory Death Is Safe and Effective
-
Gregory D. Lewis, MD
Jeffrey and Mary Ellen Jay Chair and Section Head of Heart Failure, Medical Director of Heart Transplantation
Recent Article
Higher Peak Systolic BP on Exercise Testing May Not Indicate Adverse Vascular Function
-
Judy Wei-Ming Hung, MD
Director of the Echocardiography Lab, Division of Cardiology, Professor of Medicine, Harvard Medical School
Recent Article
Tricuspid Regurgitation Uncommon After Surgery for Ischemic Mitral Regurgitation But Tied to Cardiac Events
-
Rahul Sakhuja, MD
Interventional Cardiologist, Corrigan Minehan Heart Center, Massachusetts General Hospital
Recent Article
Interventional Cardiology Studies Boost Safety in TAVR, PCI
-
Serguei Melnitchouk, MD, MPH
Cardiac Surgeon, Co-Director, Heart Valve Program, Quality Director, Division of Cardiac Surgery
Recent Article
Review: Optimal Anticoagulation After Bioprosthetic Valve Replacement
-
Thoralf M. Sundt, MD
Chief, Division of Cardiac Surgery, Co-Director, Corrigan Minehan Heart Center, Director, Cardiac Surgery Clinical Service, Mass General Brigham
Recent Article
Treating Pericardial Disease
Cardiovascular Care at Mass General
At Mass General, our world-class physicians and nurses specialize in specific forms of both heart and vascular disease, and work closely together to offer leading treatments and preventive care for cardiovascular conditions.